Catalyst Event
Samsung Biologics Co Ltd (207940) · Other
From Akros K-Manufacturing 50 Index (AKMNF50)
3/20/2026, 12:00:00 AM
CEO John Rim was re-elected for a third term at the annual general meeting on March 20, 2026, ensuring leadership continuity amid global expansion.
Korean Translation
2026년 3월 20일 정기 주주총회에서 존림 대표이사가 3연임에 성공하여 글로벌 확장 전략 속에서 리더십의 연속성을 확보함.
Related Recent Events
Samsung Biologics Co Ltd (207940) · Earnings Release
Q1 2026 earnings release is scheduled for April 29, 2026; low impact from routine disclosure expected.
4/29/2026, 12:00:00 AM
Samsung Electronics Co Ltd (005930) · Earnings Release
Analysts forecast the company will announce strong Q1 2026 earnings on April 28, 2026, with operating profit estimates around KRW 38 trillion, driven by continued strength in the semiconductor market, forecasted.
4/28/2026, 12:00:00 AM
Posco Future M Co Ltd (003670) · Earnings Release
Q1 2026 earnings release scheduled. This event is estimated to have a medium price impact of over 5%.
4/23/2026, 12:00:00 AM
Celltrion Inc (068270) · Other
The company will cancel 9.11 million treasury shares (approx. 4% of total shares) on 2026-04-01 as decided at the annual general meeting on 2026-03-24, expected.
4/1/2026, 12:00:00 AM
COWAY Co Ltd (021240) · Other
The Annual General Meeting is scheduled for March 31, 2026, amid a conflict with activist fund Align Partners over board composition and governance, leading both parties to request court-appointed inspectors for the meeting; high impact expected due to potential management changes scheduled.
3/31/2026, 12:00:00 AM
Isupetasys Co Ltd (007660) · Other
The 54th annual general meeting of shareholders is scheduled to be held on 2026-03-31. Agenda items include reporting on the approved FY2025 financial statements and the appointment of directors; the routine nature justifies a Low importance scheduled.
3/31/2026, 12:00:00 AM